In vitro activity of doripenem and comparator antimicrobial agents was evaluated against
Gram-negative bacilli recently isolated from Brazilian private hospitals that were enrolled in …

Doripenem is a broad-spectrum parenteral carbapenem recently approved in the United
States for treatment of complicated urinary tract and intra-abdominal infections. Although …

Doripenem, a new 1β-methyl parenteral carbapenem, has very broad-spectrum activity
against Gram-positive and Gram-negative aerobic bacteria. As noted here, the spectrum and …

The spectrum of activity and potency of doripenem, a broad-spectrum parenteral
carbapenem currently in clinical development, was evaluated using 16 008 clinical bacterial …

The in vitro activity of doripenem against prevalent nonfermentative Gram-negative bacilli
and Aeromonas spp. was evaluated. The collection comprised 15 236 nonduplicate clinical …

Background: Doripenem, an investigational parenteral carbapenem, exhibits a broad
spectrum of activity and favorable potency. As resistance emergence increases in the Asia …

Doripenem, a parenteral, broad-spectrum antibacterial agent of the carbapenem family, is
indicated as empirical therapy in serious bacterial infections in adults. Doripenem is …

Objectives: To summarize the results of a European-focused surveillance program
comparing activity of doripenem and other agents tested against leading contemporary …

ABSTRACT Doripenem, a 1β-methylcarbapenem, is a broad-spectrum antibiotic approved
for the treatment of complicated urinary tract and complicated intra-abdominal infections. An …

Doripenem is a new member of the carbapenem class of beta-lactam antibiotics with broad-
spectrum coverage of Gram-positive, Gram-negative and anaerobic pathogens similar to …